REGENERON PHARMACEUTICALS, INC.: net_income
| Value | {"amount": 413738000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2013-01-01 – 2013-12-31 |
| Status | current |
| Entity | REGENERON PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:39:06.709867+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/4085e19f-f3bc-40af-8a2e-b649e97b49df
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001532176-16-000045Retrieved: 2026-08-19T08:39:06.709867+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000872589/net-income/2013-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/4085e19f-f3bc-40af-8a2e-b649e97b49df
History
- supersedes {"amount": 424362000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} (evidence 0001532176-14-000008)